Dr. Rachel Occhiogrosso Abelman , MD
Internal Medicine - Hematology & Oncology โข Boston, MA
55 Fruit St
Boston, MA 021142621
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Rachel Abelman is listed in NPPES under Internal Medicine - Hematology & Oncology.
-
NPI assigned on May 11, 2018; this date does not establish years in practice.
-
Published CMS data list 153 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99215 โ Established patient outpatient office visit: 61 service units.
- G2211 โ Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's: 42 service units.
- 99215 โ Established patient outpatient office visit: 20 service units.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPTยฎ only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 5 records in the table ยท Guide: How to read Medicare Part B data
-
Published CMS data list 50 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Letrozole โ 38 prescription fills, including refills.
- Truqap (Capivasertib) โ 12 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table ยท Guide: How to read Medicare Part D prescriber data
-
Fewer Medicare Part B services than 75% of clinicians listed under Internal Medicine - Hematology & Oncology in Boston, MA (2024, 146 clinicians with data). Median for this group: 399. Middle half: 194 to 757.
Fewer Medicare Part B services than 85% of clinicians listed under Internal Medicine - Hematology & Oncology in Massachusetts (2024, 287 clinicians with data). Median for this group: 586. Middle half: 294 to 928.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part D prescriptions went from 68 in 2019 to 50 in 2024.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2019โ2024.
Practice Location & Contact Primary Location
55 Fruit St
Boston, MA 021142621
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 1 additional practice-address record in Boston, MA. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
CMS Doctors and Clinicians lists 3 distinct group names: Brigham And Womens Physicians Organization Inc; Massachusetts General Physicians Organization Inc; The General Hospital Corporation. See the list
Source: CMS Doctors and Clinicians National Downloadable File, release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
Warren Alpert Medical School Of Brown University
2018
What Public CMS Data Show
Internal Medicine - Hematology & Oncology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
66 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider, 2024.
Medicare-allowed amount
About $16,261 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
Paid by Medicare
About $12,956 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners โ by Provider and Service, 2024.
30-day fills
96 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$280,859 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers โ by Provider and Drug, 2024.
Open Payments general payments, program year 2024
All general payments: $179.02 across 4 records.
By nature of payment
- Education: $99.99 across 1 record.
- Food and Beverage: $79.03 across 3 records.
Reporting-company totals
- Pfizer Inc.: $99.99 across 1 record.
- Novartis Pharmaceuticals Corporation: $47.87 across 1 record.
- Gilead Sciences, Inc.: $31.16 across 2 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2024 (published June 30, 2026).
Years since graduation
8 years (graduated 2018)
CMS Doctors and Clinicians data list 2018 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2018
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Accepts Medicare assignment
CMS data list this clinician as accepting Medicare assignment. This means agreeing to take the Medicare-approved amount as full payment for covered services.
With Original Medicare, you usually pay only your deductible and coinsurance, and the office sends the claim to Medicare for you.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, โDoes your provider accept Medicare as full payment?โ
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Abelman has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Abelman as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Boston and Massachusetts
Billing and prescribing volume is not a quality rating.
Medicare Part B services
Fewer Medicare Part B services than 75% of clinicians listed under Internal Medicine - Hematology & Oncology in Boston, MA (2024, 146 clinicians with data). Median for this group: 399. Middle half: 194 to 757.
Fewer Medicare Part B services than 85% of clinicians listed under Internal Medicine - Hematology & Oncology in Massachusetts (2024, 287 clinicians with data). Median for this group: 586. Middle half: 294 to 928.
Medicare-allowed amount
A lower Medicare-allowed amount than 75% of clinicians listed under Internal Medicine - Hematology & Oncology in Boston, MA (2024, 146 clinicians with data). Median for this group: $45,574. Middle half: $21,997 to $81,747.
A lower Medicare-allowed amount than 85% of clinicians listed under Internal Medicine - Hematology & Oncology in Massachusetts (2024, 287 clinicians with data). Median for this group: $64,000. Middle half: $32,049 to $93,746.
Paid by Medicare
A lower Medicare payment amount than 75% of clinicians listed under Internal Medicine - Hematology & Oncology in Boston, MA (2024, 146 clinicians with data). Median for this group: $34,580. Middle half: $16,205 to $61,847.
A lower Medicare payment amount than 85% of clinicians listed under Internal Medicine - Hematology & Oncology in Massachusetts (2024, 287 clinicians with data). Median for this group: $47,819. Middle half: $24,824 to $71,249.
Medicare Part D prescriptions
Fewer Part D prescriptions than 70% of clinicians listed under Internal Medicine - Hematology & Oncology in Boston, MA (2024, 127 clinicians with data). Median for this group: 120. Middle half: 46 to 302.
Fewer Part D prescriptions than 80% of clinicians listed under Internal Medicine - Hematology & Oncology in Massachusetts (2024, 265 clinicians with data). Median for this group: 268. Middle half: 100 to 605.
Part D drug cost
Close to the middle for clinicians listed under Internal Medicine - Hematology & Oncology in Boston, MA (2024, 127 clinicians with data). Median for this group: $352,915. Middle half: $12,956 to $934,548.
A lower Part D drug cost than 60% of clinicians listed under Internal Medicine - Hematology & Oncology in Massachusetts (2024, 265 clinicians with data). Median for this group: $572,267. Middle half: $36,939 to $1,492,619.
235 active clinicians are listed under Internal Medicine - Hematology & Oncology with a practice address in Boston, MA (461 in Massachusetts).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Boston
49.8% of these 235 clinicians have the CMS telehealth indicator.
65.1% of these 235 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
CMS data for Medicare Part B services are available for 2024 only.
-
Medicare-allowed amount
CMS data for Medicare-allowed amount are available for 2024 only.
-
Paid by Medicare
CMS data for Medicare payment amount are available for 2024 only.
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 26% from 68 in 2019 to 50 in 2024.
- 2019: 68
- 2020: 87
- 2024: 50
-
30-day fills
30-day fills decreased 36% from 149 in 2019 to 96 in 2024.
- 2019: 149
- 2020: 182
- 2024: 96
-
Part D drug cost
Part D drug cost went from $709 in 2019 to $280,859 in 2024.
- 2019: $709
- 2020: $7,002
- 2024: $280,859
-
Industry payments (Open Payments)
CMS data for industry payments (Open Payments) are available for 2024 only.
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2024), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo ยท Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2024 (payments made January 1 โ December 31, 2024): fewer than 11 records totaling $179.02.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Pfizer Inc. |
Education
In-kind items and services
|
โ | General | $99.99 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
KISQALI | General | $47.87 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
Trodelvy | General | $17.44 |
| Gilead Sciences, Inc. |
Food and Beverage
In-kind items and services
|
Trodelvy | General | $13.72 |
Source: CMS Open Payments, program year 2024, released June 30, 2026.
Performed Procedures & Service Volume
CPTยฎ is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners โ by Provider and Service data, 2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
61 | 31 | $681.87 | $151.80 |
|
G2211
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's
|
42 | 18 | $70.24 | $17.34 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
20 | 18 | $651.75 | $163.64 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
19 | 19 | $435.84 | $98.73 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
11 | 11 | $487.00 | $102.17 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Letrozole | Letrozole | 38 | 2,520 | $782.07 | 20 |
| Truqap | Capivasertib | 12 | 336 | $280,076.76 | โ |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2026-01-29NUCC Taxonomy Code: 207RH0003X
An internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered.
NUCC Taxonomy Code: 207RX0202X
An internist who specializes in the diagnosis and treatment of all types of cancer and other benign and malignant tumors. This specialist decides on and administers therapy for these malignancies as well as consults with surgeons and radiotherapists on other treatments for cancer.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - HEMATOLOGY/ONCOLOGY
I20240710002979
MA
6608126495
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File
Massachusetts General Physicians Organization Inc
243 Charles St, Boston, MA 021143002
Phone: 6172735699
The General Hospital Corporation
55 Fruit St, Boston, MA 021142621
Phone: 6177262000
Brigham And Womens Physicians Organization Inc
75 Francis St, Boston, MA 021156110
Phone: 6177325500
Massachusetts General Physicians Organization Inc
55 Fruit St, Boston, MA 021142696
Phone: 6177240287
Secondary Practice Locations
75 Francis St
Boston, MA 021156110
Phone: 6177325500
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Medical Oncology
Doctor of Medicine (M.D.)
Internal Medicine - Medical Oncology
Doctor of Medicine (M.D.)
Hospitalist
Doctor of Osteopathic Medicine (D.O.)
Internal Medicine - Hematology
Bachelor of Medicine, Bachelor of Surgery (M.B.B.S.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 55 FRUIT ST, BOSTON, MA 021142696 (Tel: 6177265130)
Internal Medicine (license number reported to NPPES: MA 1017201)
Registered at 55 FRUIT ST, BOSTON, MA 021142621 (Tel: 6172319943)
Recorded as RACHEL ABELMAN, MD
NPI status registered as active in NPPES database
Registered at 75 FRANCIS ST, BOSTON, MA 021156106 (Tel: 6177326040)
Registered at 98 TOXTETH ST APT 6, BROOKLINE, MA 024466933 (Tel: 9145003986)
Recorded as RACHEL OCCHIOGROSSO, MD
Student in an Organized Health Care Education/Training Program
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Internal Medicine - Hematology & Oncology Specialists in Boston
- Dr. Jordan Wengrod, MD, PhD
- Dr. Lesley Wu, MD
- Dr. Edwin Pascal Alyea, MD
- Dr. Tamara Sussman, MD
- Dr. Jacqueline Garcia, MD
- John Clark
Mailing Address
55 Fruit St
Boston, MA 021142696
Phone: 6177265130